ASX Tech and Metals Shares: Insider Purchases Signal Confidence in South32 and Nuix
Insiders of two ASX-listed companies, South32 and Nuix, made notable share purchases this week. Their actions reflect growing confidence in...
Edwina Bartholomew Reveals Shock Cancer Diagnosis: Encourages Australians to Prioritise Health
TV star opens up about her battle with chronic myeloid leukaemia Edwina Bartholomew, a beloved Australian television presenter, recently...
Bill Shorten’s Career Shift: From Politics to $1.8 Million University Role
Former Labor leader Bill Shorten has shocked the nation by announcing his retirement from politics. After nearly two decades in public...
ASX Sees Modest Gains Despite Energy Sector Woes and US Market Slump
The Australian stock market showed modest improvement this morning after a tumultuous session on Wall Street and a rough day on the ASX...
Understanding the Fear and Opportunity: A Deep Dive into TSX’s Recent Movements
The Canadian stock market has experienced a turbulent period, with major indices showing significant fluctuations. Investors closely...
Wild Winds Set to Strike Southeast Australia Again Amid Ongoing Clean-up Efforts
Power Outages and Destruction in Victoria and Tasmania Southeast Australian states are bracing for another bout of wild winds, further...
ASX Suffers Sharp Decline Amid Global Market Sell-off
Today, the Australian share market took a significant hit, driven by a global sell-off in technology stocks, mainly Nvidia. The...
IMARC 2024: The Premier Global Mining Conference Returns to Sydney
The International Mining and Resources Conference (IMARC) 2024 is set to bring together the most influential leaders in the mining...
Paralympic Wheelchair Tennis Takes Center Stage in Paris, Not at US Open
This year’s US Open will not feature men’s and women’s wheelchair or quads tennis. The reason is simple: the world’s best...
ASX Stocks to Watch Today: Noxopharm, Percheron Therapeutics, Cyclopharm, Echo IQ, and Golden Deeps
Noxopharm’s Glioblastoma Breakthrough Noxopharm (ASX: NOX) has announced promising preclinical results in its fight against glioblastoma,...
